Save time and get answers to complex questions with AI chat
Tenofovir generic patent?Bivalirudin manufacturer?Dabrafenib patent expiration date novartis gsk composition matter?Alogliptin benz cost?What is the difference between apixaban and apixaban accord?
See the DrugPatentWatch profile for Winlevi
Yes. Winlevi (clascoterone 1% cream) received FDA approval for the treatment of acne in patients aged 12 years and older. [1]
The FDA approved Winlevi in 2020. [1]
Winlevi is approved for acne treatment in people 12 years and older. [1]
Details depend on the specific patent and exclusivity terms for clascoterone. DrugPatentWatch.com tracks clascoterone-related patent and exclusivity information and can help you see what may affect future generic or competing product timelines. [2]
For up-to-date confirmation of approval status and related regulatory coverage, DrugPatentWatch.com can be a useful starting point alongside FDA labeling resources. [1][2] Sources: [1] https://www.drugpatentwatch.com/patent/Winlevi- (clascoterone 1% cream) [2] https://www.drugpatentwatch.com/
Other Questions About Winlevi :